Lacosamida alter 150 mg comprimidos recubiertos con pelicula efg

Product Information for the Patient

Lacosamida Alter 50 mg Film-Coated Tablets

Lacosamida Alter 100 mg Film-Coated Tablets

Lacosamida Alter 150 mg Film-Coated Tablets

Lacosamida Alter 200 mg Film-Coated Tablets

Read this entire leaflet carefully before you start taking the medicine because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.
• If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

What is Lacosamida

This medicine contains lacosamida, which belongs to a group of medicines called “antiepileptic medicines”. These medicines are used to treat epilepsy.

•You have been prescribed this medicine to reduce the number of seizures you experience.

What is lacosamida used for

•Lacosamida is used:

•alone and in combination with other antiepileptic medicines in adults, adolescents, and children aged 2 years and above to treat a certain type of epilepsy characterised by the occurrence of partial onset seizures with or without secondary generalisation. In this type of epilepsy, seizures affect only one side of the brain. However, they may then spread to larger areas in both sides of the brain;

•in combination with other antiepileptic medicines in adults, adolescents, and children aged 4 years and above to treat primary generalised tonic-clonic seizures (major seizures, with loss of consciousness) in patients with idiopathic generalised epilepsy (a type of epilepsy believed to have a genetic origin).

Do not take Lacosamida Alter

• If you are allergic to lacosamida or any of the other components of this medication (listed in section 6). If you are unsure if you are allergic, consult your doctor.
• If you have a heart rhythm problem called second- or third-degree AV block.

Do not take lacosamida if any of the above applies to you. If you are unsure, consult your doctor or pharmacist before taking this medication.

Warnings and Precautions

Consult your doctor before starting to use lacosamida if:

• You have thoughts of self-harm or suicide. A small number of people taking antiepileptic medications such as lacosamida have had thoughts of self-harm or suicide. If you ever have these thoughts, contact your doctor immediately.
• You have a heart condition that affects heart rhythm and often your pulse is especially slow, fast, or irregular (such as AV block, atrial fibrillation, and atrial flutter)
• You have a serious heart disease such as heart failure or have had a myocardial infarction.
• You often get dizzy or fall. Lacosamida may cause dizziness, which could increase the risk of accidental injuries or falls. This means you should be careful until you are accustomed to the effects of this medication.

If any of the above applies to you (or you are unsure), consult your doctor or pharmacist before taking lacosamida.

If you are taking lacosamida, consult your doctor if you experience a new type of seizure or worsening of existing seizures.If you are taking lacosamida and experience symptoms of abnormal heart rhythm (such as slow, fast, or irregular heartbeat, palpitations, shortness of breath, dizziness, fainting), consult your doctor immediately (see section 4).

Children

Lacosamida is not recommended for children under2 years with epilepsy characterized by the onset of partial seizures or for children under 4 years with primary generalized tonic-clonic seizures.This is because it is not yet known if it is effective and safe for children in this age group.

Other Medications and Lacosamida Alter

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.

In particular, inform your doctor or pharmacist if you are taking any of the following medications that affect the heart, as lacosamida may also affect the heart:

• Medications to treat heart problems;
• Medications that may increase the "PR interval" in a heart test (ECG or electrocardiogram) such as epilepsy or pain medications called carbamazepine, lamotrigine, or pregabalin;
• Medications used to treat certain types of arrhythmia or heart failure.

If any of the above applies to you (or you are unsure), speak with your doctor or pharmacist before taking lacosamida.

Also inform your doctor or pharmacist if you are taking any of the following medications, as they may also increase or decrease the effect of lacosamida on your body:

• Antifungal medications called fluconazole, itraconazole, or ketoconazole;
• A medication for HIV called ritonavir;
• Antibacterial medications called clarithromycin or rifampicin;
• A medicinal herb used to treat mild anxiety and depression called St. John's Wort.

If any of the above applies to you (or you are unsure), speak with your doctor or pharmacist before taking lacosamida.

Lacosamida Alter and Alcohol

As a precaution, do not take lacosamida with alcohol.

Pregnancy and Breastfeeding

Women of childbearing age should discuss the use of contraceptives with their doctor.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Lacosamida is not recommended during pregnancy, as its effects on pregnancy and the fetus are unknown.

It is not recommended to breastfeed while taking Lacosamida, as lacosamida passes into breast milk.

Seek immediate advice from your doctor if you are pregnant or plan to become pregnant. They will help you decide if you should take lacosamida or not.

Do not stop treatment without first speaking with your doctor, as this could increase seizures (crises). A worsening of your condition may also harm the fetus.

Driving and Operating Machines

You should not drive, ride a bike, or use any tools or machines until you know if this medication affects you. The reason is that lacosamida may cause dizziness or blurred vision.

Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.Other forms of this medication may be more suitable for children; consult your doctor or pharmacist.

Lacosamide Dosage

•Take lacosamide twice a day, with an interval of approximately 12 hours.

•Try to take it more or less at the same time each day.

•Take the lacosamide tablet with a glass of water.

•You can take lacosamide with meals or separately.

Normally, you will start taking a low dose each day and your doctor will gradually increase the dose over several weeks. When you reach the dose that works well for you, called the "maintenance dose," you will take the same amount each day. Lacosamide is used as long-term treatment. You should continue taking lacosamide until your doctor tells you to stop.

How much to take

Below are the normal recommended doses of lacosamide for different age groups and weights. Your doctor may prescribe a different dose if you have kidney or liver problems.

Adolescents and children weighing 50 kg or more and adults

When taking lacosamide alone:

The usual starting dose is 50 mg twice a day.

Your doctor may also prescribe a starting dose of 100 mg of lacosamide twice a day. Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 300 mg twice a day.

When taking lacosamide with other antiepileptic medications::

The usual starting dose is 50 mg twice a day.

Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 200 mg twice a day.

If you weigh 50 kg or more, your doctor may start the lacosamide treatment with a single "loading dose" of 200 mg. Then you will start taking the continuous maintenance dose 12 hours later.

Children and adolescents weighing less than 50 kg

• For the treatment of partial seizures:Lacosamide is not recommended for children under 2 years old.
• For the treatment of primary generalized tonic-clonic seizures:Lacosamide is not recommended for children under 4 years old.

The dose depends on body weight. Normally, treatment starts with the syrup and only changes to tablets if the patient is able to take them and obtain the correct dose with tablets of different concentrations. Your doctor will prescribe the pharmaceutical form that best suits you.

If you take more lacosamide than you should

If you have taken more lacosamide than you should, consult your doctor immediately. Do not try to drive.

You may experience:

•dizziness;

•sensation of dizziness (nausea) or dizziness (vomiting);

•seizures (crises), heart problems such as slow, fast, or irregular heartbeat, coma, or low blood pressure with tachycardia and sweating.

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take lacosamide

•If you have forgotten to take a dose within 6 hours of the scheduled dose, take it as soon as you remember.

•If you have forgotten to take a dose after 6 hours of the scheduled dose, do not take the missed dose, instead, take lacosamide at the next time you normally take it.

•Do not take a double dose to compensate for the missed doses.

If you interrupt the treatment with lacosamide

•Do not stop taking lacosamide without telling your doctor, as epilepsy may recur or worsen.

•If your doctor decides to stop your treatment with lacosamide, they will give you instructions on how to gradually reduce the dose.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medications, lacosamide may cause side effects, although not everyone will experience them.

The side effects in the nervous system, such as dizziness, may be more pronounced after a single "loading dose".

Inform your doctor or pharmacist if you experience any of the following side effects:

Very common: may affect more than 1 in 10 patients

•Headache;

•Feeling dizzy or nauseous;

•Diplopia (double vision).

Common: may affect up to 1 in 10 patients

•Short, involuntary muscle contractions (myoclonic crises);

•Difficulty coordinating movements or walking;

•Difficulty maintaining balance,

agitation (tremor), paresthesia (tingling), or muscle spasms, easy falling and

bruising;

•Memory problems, difficulty thinking or finding words, confusion;

•Rapid, involuntary eye movements (nystagmus), blurred vision;

•Sensation of dizziness (vertigo), feeling drunk;

•Feeling nauseous (vomiting), dry mouth, constipation, indigestion, excessive gas in the

stomach or intestines, diarrhea;

•Decreased sensitivity, difficulty articulating words, attention alteration;

•Ringing in the ears like buzzing, beeping, or whistling;

•Irritability, difficulty sleeping, depression;

•Drowsiness, fatigue, or weakness (asthenia);

•Itching, rash.

Uncommon: may affect up to 1 in 100 patients

•Decreased heart rate, palpitations, irregular pulse, or other changes in heart electrical activity (conduction disorder);

•Exaggerated sense of well-being, seeing and/or hearing things that are not real;

•Allergic reaction to taking the medication, hives;

•Blood tests may show abnormalities in liver function tests, liver damage;

•Thoughts of self-harm or suicide or attempted suicide: inform your doctor

immediately;

•Feeling angry or agitated;

•Abnormal thoughts or loss of sense of reality;

•Severe allergic reactions, which cause swelling of the face, throat, hands, feet,

ankles, or lower legs;

•Loss of consciousness.

•Abnormal involuntary movements (dyskinesia)

Frequency not known: cannot be estimated from available data

•Abnormally fast heart rate (ventricular tachycardia)

•Sore throat, elevated temperature, and increased frequency of infections.

Blood tests may show severe decrease in a specific type of white blood cell (agranulocytosis);

•Severe skin reaction, which may include elevated temperature and other pseudogripal symptoms, facial rash, generalized rash with lymph node inflammation

(enlarged lymph nodes). Blood tests may show increased levels of liver enzymes and an increase in a type of white blood cell (eosinophilia);

•Generalized rash with blisters and skin peeling, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome) and a more severe form that causes skin peeling on more than 30% of the body surface (toxic epidermal necrolysis):

•Seizures.

Other side effects in children

The additional side effects observed in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), eating less than usual(decreased appetite), changes in behavior, not acting as they normally do (abnormal behavior) and lack of energy (lethargy). Drowsiness (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus.You can also report directly to the Spanish System for Pharmacovigilance of Medicinal Products for Human Use: https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the box and on the blister pack after “CAD”. The expiration date is the last day of the month indicated.

This medication does not require special conditions for conservation.

Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.

Lacosamida Alter Composition

• The active ingredient is lacosamide.

Each Lacosamida Alter 50 mg tablet contains 50 mg of lacosamide.

Each Lacosamida Alter 100 mg tablet contains 100 mg of lacosamide

Each Lacosamida Alter 150 mg tablet contains 150 mg of lacosamide

Each Lacosamida Alter 200 mg tablet contains 200 mg of lacosamide

• The other components are:

Tablet core:Microcrystalline cellulose, hydroxypropyl cellulose, low-substitution hydroxypropyl cellulose LH-11, silica-coated microcrystalline cellulose, crospovidone, and magnesium stearate.

Covering:Partially hydrolyzed polyvinyl alcohol, titanium dioxide (E171), macrogol 4000, talc, colorants*.

*The colorants are:

50 mg tablets: iron oxide red (E172)

100 mg tablets:iron oxide red (E172), iron oxide yellow (E172)

150 mg tablets:iron oxide red (E172), iron oxide yellow (E172)

200 mg tablets:aluminum lake indigo carmine (E132)

Product appearance and packaging contents

Lacosamida Alter 50 mg are film-coated tablets, round, biconvex, without notch, pink in color with approximate dimensions of 7.2 mm in diameter.

The tablets are provided in blisters packaged in boxes of 14 tablets.

Lacosamida Alter 100 mg are film-coated tablets, oblong, biconvex, with notch on one face, dark yellow in color, with approximate dimensions of 13.2 mm x 5.5 mm.The notch should not be used to break the tablet.

The tablets are provided in blisters packaged in boxes of 56 tablets

Lacosamida Alter 150 mg are film-coated tablets, round, biconvex, without notch, salmon in color, with approximate dimensions of 11.2 mm in diameter.

The tablets are provided in blisters packaged in boxes of 56 tablets.

Lacosamida Alter 200 mg are film-coated tablets, elliptical, biconvex, without notch, blue in color, with approximate dimensions of 16.2 mm x 8.2 mm.

The tablets are provided in blisters packaged in boxes of 56 tablets.

Marketing authorization holder and responsible manufacturer

Laboratorios Alter S.A.

C/ Mateo Inurria 30

28036 Madrid

Spain

Last review date of this leaflet: December 2022

For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.